Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004335111 | SCV004054332 | uncertain significance | not specified | 2023-08-02 | criteria provided, single submitter | clinical testing | The c.656A>G (p.N219S) alteration is located in exon 6 (coding exon 4) of the GLTSCR1 gene. This alteration results from a A to G substitution at nucleotide position 656, causing the asparagine (N) at amino acid position 219 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003919063 | SCV004743139 | likely benign | BICRA-related disorder | 2022-07-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |